Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 2, 2003, Pages 230-233

  Meng, Xue Qin ^a   Chen, Hu Guang ^a   Ma, Yi Lin ^a   Liu, Ke Zhou ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Allelle; Hepatitis B; HLA

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQ9 ANTIGEN; HLA DR ANTIGEN; HLA DR12 ANTIGEN; HLA DR9 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIGEN DETECTION; ARTICLE; CHINA; CHRONIC HEPATITIS; CHRONICITY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK ASSESSMENT;

ADULT; ALLELES; CHINA; FEMALE; HEPATITIS B, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS;

EID: 0038205507     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thursz MR, Kwiatkowski K, Allsopp GEM, et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. Nengl J Med 1995; 332:1065-1069.
2. Holder T, Gerken G, Notghi A, et al. HLA-DRB1 * 1301 and 1302 protect against hepatitis B. J Hepatol 1997;26:503-507.
3. Thio CL, Carrington M, Marti D, et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Inf Dis 1999;179:1004-1006.
4. Neumann UP, Langrehr JM, Naumann U, et al. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis. Clin Transplantation 2002;16:122.
5. Ahn SH, Han KH, Park JY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000;31:1371-1373.
6. The Program for Prophylaxis and Treatment of Viral Hepatitis (Trial). Chin J Infect Dis 1995;13:241-247.
7. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998;113:244-251.
8. (+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen Virol 2002;83:3023-3033.
9. Cao MD. HLA molecule biology and its clinical application. Zhengzhou: Publishing House of Henan Medical University 1998,32-43.
10. Qian Y, Zhang L, Lang XM, et al. Association of immune response to hepatitis B vaccine with HLA-DRB1 * 02, 07, 09 genes in the population of Han nationality in Guangdong province. Di Yi Jun Yi Da Xue Xue Bao 2002;22:67-69.
11. Salazar M, Deulofeut H, Granja C, et al. Normal HB-sAg presentation and T-cell defect in the immune response of non-responders. Immunogenetics 1995;46: 366-374.